A Randomised Controlled Trial of Omega 3 Fatty Acids in the Management of Antipsychotic-Induced Movement Disorders
- Conditions
- Mental and Behavioural Disorders
- Registration Number
- PACTR202108856656364
- Lead Sponsor
- Dr Sammy Ohene
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
A confirmed diagnosis of antipsychotic-induced movement disorder
Participants aged between 18 and 60years.
On a stable dose of antipsychotic medication within 3 months prior to study
Patients in the control arm should not have initiated anti-cholinergic therapy
Patients should demonstrate a commitment not to initiate or modify interventions during the period of the study.
Patients whose psychiatric disorder was not stable;
Patients with a significant organic neurological disorder other than the mental disorder
Treatment with omega-3 therapy 3months prior to study
Patients who were pregnant or breastfeeding.
Patients with a diagnosis of substance dependence (DSM-IV),
Patients with a known allergy to omega 3 fish oil or sea foods
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method